ImmunoScape is a pre-clinical biotechnology company based in Singapore and San Diego, US, specializing in the discovery and development of next-generation TCR-T cell therapies for oncology. Leveraging their Deep Immunomics and Machine Learning platforms, ImmunoScape is focused on creating a diverse portfolio of novel TCRs against solid tumors, employing a multi-pronged approach to develop highly effective and differentiated T cell receptor-based therapeutics.
With a continuously generating discovery engine, ImmunoScape is rapidly advancing assets towards clinical candidate nomination, aiming to address the unmet needs in the field of solid tumor treatment. Their pipeline consists of various cell therapy programs targeting solid tumors, and they have established collaborations with organizations such as Singapore's Experimental Drug Development Centre and MiNK Therapeutics to accelerate the identification and development of novel TCR-based therapeutics.
Generated from the website